Literature DB >> 12702988

Identification of patients with hepatitis C virus infection in New Haven County primary care practices.

Victor J Navarro1, Thomas E St Louis, Beth P Bell.   

Abstract

BACKGROUND: Primary care providers (PCPs) must identify persons at risk for hepatitis C virus (HCV) infection, test them correctly, refer to subspecialists, and use published guidelines. The objectives of this study were to describe HCV practices of New Haven County PCPs. STUDY: All 652 PCPs in New Haven County, Connecticut, were surveyed to determine practices related to hepatitis C, including risk factor ascertainment, testing routines, use of published guidelines, and referral practices.
RESULTS: Of 181 eligible respondents, 143 (79%) were internal medicine physicians and 38 (21%) were family practitioners. Eighty-four PCPs (46%) routinely asked about a history of blood transfusion, and 112 (62%) routinely asked about a history of injection drug use (IDU). Most PCPs would test current or past IDU (91% versus 83%, respectively), persons transfused prior to 1992 (79%), health care workers with a history of a needle stick accident (88%), and a child born to an HCV-infected mother (76%). PCPs frequently referred patients with hepatitis C to gastroenterologists. Most PCPs (76%) were familiar with available hepatitis C testing guidelines.
CONCLUSIONS: Most PCPs test for HCV infection appropriately, but many do not elicit risk factor histories that could identify such persons. More effective training with emphasis on eliciting a history of pertinent risk factors is needed.

Entities:  

Mesh:

Year:  2003        PMID: 12702988     DOI: 10.1097/00004836-200305000-00015

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity.

Authors:  Stacey B Trooskin; Victor J Navarro; Robert J Winn; David J Axelrod; A Scott McNeal; Maricruz Velez; Steven K Herrine; Simona Rossi
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

2.  Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

Authors:  Reena Mahajan; Stephen J Liu; R Monina Klevens; Scott D Holmberg
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

3.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

4.  Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Authors:  Amy Jewett; Arika Garg; Katherine Meyer; Laura Danielle Wagner; Katherine Krauskopf; Kimberly A Brown; Jen-Jung Pan; Omar Massoud; Bryce D Smith; David B Rein
Journal:  Health Promot Pract       Date:  2014-04-28

5.  Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010.

Authors:  Rania A Tohme; Jian Xing; Youlian Liao; Scott D Holmberg
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

6.  Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.

Authors:  Robert R Leverence; Robert L Williams; Wilson Pace; Bennett Parnes; Yvonne Fry-Johnson; Dorothy R Pathak; Betty Skipper; Elvan Daniels; Philip Kroth
Journal:  J Am Board Fam Med       Date:  2009 Nov-Dec       Impact factor: 2.657

Review 7.  The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries.

Authors:  A Bechini; M Levi; A Falla; A Ahmad; I Veldhuijzen; E Tiscione; P Bonanni
Journal:  J Prev Med Hyg       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.